Filed: 2026-10-02 AccNo: 0001437749-26-031895 Size: 243 KB Item 3.03: Material Modifications to Rights of Security Holders Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 5.07: Submission of Matters to a Vote of Security Holders Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Catheter Precision, a subsidiary of Flyte Aviation, announced the successful completion of its first commercial procedure using the VIVO 3D imaging system at Klinikum Bayreuth in Germany.
Flyte Aviation, Inc. (formerly Catheter Precision, Inc.) has executed a non-binding Letter of Intent to sell its legacy medical device business, including the VIVO and LockeT product lines.
Catheter Precision, a subsidiary of Flyte Aviation, announced that its VIVO 3D imaging system has received FDA 510(k) clearance for expanded labeling in its Indications for Use statement.
Catheter Precision published a peer-reviewed study in The Journal of Interventional Cardiology demonstrating the safety and efficacy of its LockeT device compared to traditional vascular closure methods.